Researchers build online glaucoma simulator
Researchers at the University of Toronto have built an online simulator that gives an improved visual representation of the deterioration caused by glaucoma.
Sep 21, 2023
0
6
Researchers at the University of Toronto have built an online simulator that gives an improved visual representation of the deterioration caused by glaucoma.
Sep 21, 2023
0
6
There is an adverse association between calcium channel blocker (CCB) use and glaucoma, according to a study published online Sept. 7 in JAMA Ophthalmology.
Sep 9, 2023
0
14
It can be hard to know that you have glaucoma. In a study carried out at the University of Gothenburg, almost 5% of 70-year-olds were found to have glaucoma, and half of those diagnosed were unaware that they had the disease.
Sep 7, 2023
0
1
A team of medical scientists at the University of Electronic Science and Technology of China, working with a colleague from the Army Medical University and another from the Luzhou Maternal and Child Health Hospital, has found ...
Treatment can control the symptoms of the most common type of glaucoma and save someone's vision.
Jul 14, 2023
0
2
Glaucoma, an eye disease that can cause irreversible blindness, is a major health concern worldwide. It is caused by a build-up of fluid in the eye, which leads to increased pressure inside the eye. This pressure can in turn ...
Jul 6, 2023
0
3
International research led by QIMR Berghofer has found hundreds of new genes linked to a person's risk of developing glaucoma, including key genetic targets that could, for the first time, pave the way for treatments that ...
Jul 3, 2023
0
59
Macquarie Medical School researchers have developed a technique for a gene therapy that could help treat the world's leading cause of irreversible blindness. The findings are published in the journal Molecular Therapy.
Jun 27, 2023
0
36
Glaucoma is the leading cause of irreversible blindness worldwide. Primary open-angle glaucoma (POAG) is the most common form, and yet the cause of this disease is poorly understood. Findings from previous genome-wide association ...
Jun 13, 2023
0
6
Indiana University School of Medicine researchers have identified a new therapeutic target that could lead to more effective treatment of glaucoma.
Mar 10, 2023
0
40
Glaucoma refers to a group of diseases that affect the optic nerve and involves a loss of retinal ganglion cells in a characteristic pattern. It is a type of optic neuropathy. Raised intraocular pressure is a significant risk factor for developing glaucoma (above 22 mmHg or 2.9 kPa). One person may develop nerve damage at a relatively low pressure, while another person may have high eye pressure for years and yet never develop damage. Untreated glaucoma leads to permanent damage of the optic nerve and resultant visual field loss, which can progress to blindness.
Glaucoma can be divided roughly into two main categories, "open angle" and "closed angle" glaucoma. Angle closure can appear suddenly and is often painful. Visual loss can progress quickly but the discomfort often leads patients to seek medical attention before permanent damage occurs. Open angle, chronic glaucoma tends to progress more slowly and the patient may not notice that they have lost vision until the disease has progressed significantly.
Glaucoma has been nicknamed the "sneak thief of sight" because the loss of vision normally occurs gradually over a long period of time and is often only recognized when the disease is quite advanced. Once lost, this damaged visual field can never be recovered. Worldwide, it is the second leading cause of blindness. Glaucoma affects one in two hundred people aged fifty and younger, and one in ten over the age of eighty. If the condition is detected early enough it is possible to arrest the development or slow the progression with medical and surgical means.
This text uses material from Wikipedia, licensed under CC BY-SA